MIDCAB | Hybrid | Total | |
---|---|---|---|
(n = 138) | (n = 62) | (N = 200) | |
Age, year | 63.65 ± 10.48 | 60.24 ± 9.18 | 62.59 ± 10.19 |
Sex, N (%) of female | 35 (25.4 %) | 10 (16.1 %) | 45 (22.5 %) |
Height, cm | 167.08 ± 7.4 | 168.3 ± 6.32 | 167.45 ± 7.1 |
Weight, kg | 70.69 ± 10.53 | 71.73 ± 9.52 | 71.01 ± 10.21 |
Hypertension, N (%) | 80 (58.0 %) | 26 (41.9 %) | 106 (53.0 %) |
Diabetes mellitus, N (%) | 40 (29.0 %) | 27 (43.5 %) | 67 (33.5 %) |
Smoking, N (%) | 63 (45.7 %) | 33 (53.2 %) | 96 (48.0 %) |
Hypercholesterolemia, N (%) | 20 (14.5 %) | 9 (14.5 %) | 29 (14.5 %) |
Old MI, N (%) | 40 (29.0 %) | 17 (27.4 %) | 57 (28.5 %) |
PCI history, N (%) | 17 (12.3 %) | 0 (0.0 %) | 17 (8.5 %) |
Renal insufficiency, N (%) | 4 (2.9 %) | 0 (0.0 %) | 4 (2.0 %) |
NYHA grade 1-2, N (%) | 120 (87.0 %) | 55 (88.7 %) | 175 (87.5 %) |
NYHA grade 3, N (%) | 18 (13.0 %) | 7 (11.3 %) | 25 (12.5 %) |
LVEF, N (%) | |||
> 55 % | 114 (82.6 %) | 52 (83.9 %) | 166 (83.0 %) |
46–55 % | 16 (11.6 %) | 3 (4.8 %) | 19 (9.5 %) |
36–45 % | 7 (5.1 %) | 6 (9.7 %) | 13 (6.5 %) |
≤ 35 % | 1 (0.7 %) | 1 (1.6 %) | 2 (1.0 %) |
LVEDd, mm | 50.16 ± 5.96 | 50.52 ± 5.76 | 50.27 ± 5.89 |
Single-vessel disease | 89 (64.5 %) | 0 (0.0 %) | 89 (44.5 %) |
Left main or multi-vessel disease | 49 (35.5 %) | 62 (100.0 %) | 111 (55.5 %) |